Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FK4GC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,657
Award facts
- Contract value 100% obligated
- $15,657.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $15,657.22 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging). This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a non-competitive procurement for a brand-name anticoagulant medication. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a single-award vehicle valued at up to $999,999,999.00 through December 31, 2031, which enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, specializing in delivering both brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to military treatment facilities and other government healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, the company has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition. The delivery of Eliquis reflects AmerisourceBergen's ongoing role in supporting the Defense Health Agency and broader military healthcare operations with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FK4GC?
SPE2DR26FK4GC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FK4GC worth?
The government has obligated $15,657 on SPE2DR26FK4GC.
Is contract SPE2DR26FK4GC an order under another contract?
Yes. SPE2DR26FK4GC is a delivery order under SPE2DR25D3019, an indefinite delivery contract.
Was contract SPE2DR26FK4GC competed?
The extent of competition for SPE2DR26FK4GC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award